Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Tolinapant by Taiho Pharmaceutical for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Bile Duct Cancer (Cholangiocarcinoma). According to...
Tolinapant by Taiho Pharmaceutical for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Human Epidermal Growth Factor Receptor 2...
Tolinapant by Taiho Pharmaceutical for Anaplastic Large Cell Lymphoma (ALCL): Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase II for Anaplastic Large Cell Lymphoma (ALCL). According...
Tolinapant by Taiho Pharmaceutical for T-Cell Lymphomas: Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase II for T-Cell Lymphomas. According to GlobalData, Phase...
Tolinapant by Taiho Pharmaceutical for Glioblastoma Multiforme (GBM): Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...
Tolinapant by Taiho Pharmaceutical for T-Cell Leukemia: Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase II for T-Cell Leukemia. According to GlobalData, Phase...
Tolinapant by Taiho Pharmaceutical for Metastatic Colorectal Cancer: Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
Tolinapant by Taiho Pharmaceutical for Hepatocellular Carcinoma: Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase...
Tolinapant by Taiho Pharmaceutical for Pancreatic Cancer: Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase...
Tolinapant by Taiho Pharmaceutical for Head And Neck Cancer: Likelihood of Approval
Tolinapant is under clinical development by Taiho Pharmaceutical and currently in Phase I for Head And Neck Cancer. According to...